Skip to main content

Table 3 Factors that were found to affect the long-term prognosis in IgAN patients in the univariate and multivariate COX regression analyses

From: Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission

 

Univariate analysis

  

Multivariate analysis

 
 

HR

95% CI

P value

HR

95% CI

P value

ALB g/L at month 6

0.86

0.76-0.96

0.01

  

NS

TA-ALB g/L

0.8

0.70-0.93

0.002

0.86

0.75-0.98

0.03

Baseline SCr μmol/L

1.02

1.01-1.04

0.003

  

NS

SCr μmol/L at month 3

1.03

1.02-1.05

<0.001

  

NS

SCr μmol/L at month 6

1.03

1.02-1.04

<0.001

  

NS

TA-SCr μmol/L

1.02

1.01-1.03

<0.001

1.02

1.01-1.03

<0.001

Baseline BUN mmol/L

1.37

1.14-1.65

0.001

  

NS

BUN mmol/L at month 3

1.35

1.15-1.59

<0.001

  

NS

BUN mmol/L at month 6

1.36

1.10-1.69

0.005

  

NS

TA-BUN mmol/L

1.56

1.25-1.94

<0.001

  

NS

Baseline eGFR (ml/min/1.73 m2)

0.97

0.94-0.99

0.01

  

NS

eGFR (ml/min/1.73 m2) at month 3

0.96

0.94-0.98

0.004

  

NS

eGFR (ml/min/1.73 m2) at month 6

0.96

0.93-0.98

0.001

  

NS

TA-eGFR (ml/min/1.73 m2)

0.96

0.93-0.98

0.001

  

NS

UPE (g/d) at month 3

1

1.00-1.002

0.003

  

NS

TA-UPE (g/d)

1

1.000-1.002

0.01

  

NS